Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 1, 2011, Pages 54-59

  Espinel Ingroff, Ana ^a   Cantón, Emilia ^b   Pelaez, Teresa ^c   Pemán, Javier ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Etest micafungin; Etest versus reference MICs; Micafungin MICs; Micafungin MICs for Candida

Indexed keywords

MICAFUNGIN;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; EPSILOMETER TEST; FKS GENE; FUNGAL GENE; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PICHIA GUILLIERMONDII; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; ECHINOCANDINS; HUMANS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS;

EID: 79955037957     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.12.010     Document Type: Article

References (23)

1. Baixench M.T., Aoun N., Desnos-Ollivier M., Garcia-Hermoso D., Bretagne S., Ramires S., Piketty C., Dannaoui E. Acquired resistance to echinocandins in Candida albicans: case report and review. J. Antimicrob. Chemother. 2007, 59:1076-1083.
2. Cantón E., Espinel-Ingroff A., Pemán J., del Castillo L. In vitro fungicidal activities of echinocandins against Candida metapsilois, C. orthopsilosis and C. parapsilosis evaluated by time-kill studies. Antimicrob. Agents Chemother. 2010, 54:2194-2197.
3. Cantón E., Pemán J., Valentín A., Espinel-Ingroff A., Gobernado M. In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies. Antimicrob. Agents Chemother. 2009, 53:3108-3111.
4. Clinical and Laboratory Standards Institute (CLSI) Development of in vitro susceptibility testing criteria and quality control parameters; approved standard, third edition, M23-A3 2007, CLSI, Wayne, PA.
5. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, third edition, M27-A3 2008, CLSI, Wayne, PA.
6. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts; informational supplement, third edition, M27-S3 2008, CLSI, Wayne, PA.
7. Clinical and Laboratory Standards Institute (CLSI) 2010.
8. Dalhoff A., Ambrose P.G., Mouton J.W. A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints. Infection 2009, 37:296-305.
9. Desnos-Ollivier M., Bretagne S., Raoux D., Hoinard D., Dromer F., Dannaoui E. Mutations in the fks1 gene in Candida albicans, C. tropicalis and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob. Agents Chemother. 2008, 52:3092-3098.
10. Douglas C.M., D'Ippolito J.A., Shei G.J., Meinz M., Onishi J., Marrinan J.A., Li W., Abruzzo G.K., Flattery A., Bartizal K., Mitchell A., Kurtz M.B. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-β-d-glucan synthase inhibitors. Antimicrob. Agents Chemother. 1997, 41:2471-2479.
11. Espinel-Ingroff A., Canton E., Martin-Mazuelos E., Pemán J. Pharmacotherapy of Candida infections with echinocandins. Clin. Med. Therapeutics. 2009, 1:889-897.
12. Espinel-Ingroff A., Canton E., Martin-Mazuelos E., Pemán J. Comparison of anidulafungin MICs determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates. Antimicrob. Agents Chemother. 2010, 54:1347-1350.
13. Food and Drug Administration Class II special controls guidance document:antimicrobial susceptibility test systems; guidance for industry 2003, Food and Drug Administration, Washington, DC.
14. Garcia-Effron G., Park S., Perlin D.S. Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob. Agents Chemother. 2009, 53:112-122.
15. Garcia-Effron G., Lee S., Park S., Cleary J.D., Perlin D.S. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-β-d-glucan synthase: implications for the existing breakpoint. Antimicrob. Agents Chemother. 2009, 53:3690-3699.
16. Jacobsen M.D., Whyte J.A., Odds F.C. Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro. Antimicrob. Agents Chemother. 2007, 51:1882-1884.
17. Kahn J.N., Garcia-Effron G., Hsu M.J., Park S., Marr K.A., Perlin D.S. Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase. Antimicrob. Agents Chemother. 2007, 51:1876-1878.
18. Pappas P.G., Kauffman C.A., Andes D., Benjamin D.K., Calandra T.F., Edwards J.E., Filler S.G., Fisher J.F., Kullberg B.J., Ostrosky-Zeichner L., Reboli A.C., Rex J.H., Walsh T.J., Sobel J.D. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 48:503-535.
19. Pfaller M.A., Diekema D.J., Andes D., Arendrup M.C., Brown S.D., Motyl M., Perlin D.S. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria 2011, and the CLSI Subcommittee for Antifungal Testing, Under revision.
20. Pfaller M.A., Boyken L., Hollis R.J., Kroeger J., Messer A., Tendolkar S., Jones R.N., Diekema D.J. Wild-type MIC distribution and epidemiological cutoff values for the echinocandins and Candida spp. J. Clin. Microbiol. 2010, 48:52-62.
21. Pfaller M.A., Castanheira M., Diekema D.J., Messer S.A., Moet G.J., Jones R.N. Comparison of EUCAST and Etest methods with CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. J. Clin. Microbiol. 2010, 48:1592-1599.
22. Turnidge J., Kahmeter G., Kronvall G. Statistical characterization of bacterial wild- type MIC value distributions and the determination of epidemiological cut-off values. Clin. Microbiol. Infect. 2006, 12:418-425.
23. Turnidge J., Patterson D.L. Setting and revising antibacterial breakpoints. Clin. Microbiol. Rev. 2007, 20:391-408.